Please use this identifier to cite or link to this item: https://ahro.austin.org.au/austinjspui/handle/1/12412
Title: Reported ingested dose of paracetamol as a predictor of risk following paracetamol overdose.
Austin Authors: Leang, Y ;Taylor, D M;Dargan, Paul I;Wood, D M;Greene, Shaun L 
Affiliation: Austin Health, Heidelberg, Melbourne, Australia
Issue Date: 1-Oct-2014
Publication information: European Journal of Clinical Pharmacology 2014; 70(12): 1513-8
Abstract: To evaluate reported ingested dose of paracetamol as a risk assessment tool in acute paracetamol overdose.Data was retrospectively obtained from a clinical toxicology database linked to one Australian and two United Kingdom hospitals. Plasma paracetamol concentrations (PPCs) of adult patients presenting with acute single ingestion, non-staggered paracetamol deliberate self-poisoning between 2006 and 2012 were recorded and plotted on a treatment nomogram to determine accuracy of reported dose ingested as an indicator for antidotal treatment. PPC plotted on a treatment nomogram with a line intersecting a 4-h concentration of 100 mg/L [667 μmol/L] was considered an indication for antidotal treatment in the UK; the corresponding Australasian population utilised a line intersecting 150 mg/L [1000 μmol/L].Of 1246 patients, 65.7 % were female and 88 % were from the UK. Fifty-two percent of patients reporting ingestion of ≥8 g paracetamol had a PPC above the 100 mg/L treatment line; PPV 52 % [95 % confidence interval (CI) 49 %, 55 %], sensitivity 81 % [95 %CI 78 %, 85 %]. Forty-four of patients reporting percent ingestion of ≥10 g had a PPC above the 150 mg/L treatment line; PPV 44 % [95 % CI 41 %, 49 %], sensitivity 85 % [95 % CI 78 %, 89 %], 72 % of patients reporting ingestion of ≥16 g had a PPC above the 100 mg/L treatment line; PPV 72 % [95% CI 67 %, 77 %], sensitivity 50 % [95 % CI 45 %, 54 %]. Overall, there was moderate correlation (R = 0.58) between reported paracetamol dose ingested and extrapolated 4-h PPC.There is a positive correlation between reported ingested dose of paracetamol and subsequent chance of a PPC being above a defined treatment line; however, ingested dose of paracetamol alone is a poor risk assessment tool in accurately determining need for treatment with an antidote.
Gov't Doc #: 25270975
URI: https://ahro.austin.org.au/austinjspui/handle/1/12412
DOI: 10.1007/s00228-014-1756-0
Journal: European journal of clinical pharmacology
URL: https://pubmed.ncbi.nlm.nih.gov/25270975
Type: Journal Article
Appears in Collections:Journal articles

Files in This Item:
File SizeFormat 
25270975.pdf50.38 kBAdobe PDFView/Open
Show full item record

Page view(s)

28
checked on Nov 28, 2024

Download(s)

92
checked on Nov 28, 2024

Google ScholarTM

Check


Items in AHRO are protected by copyright, with all rights reserved, unless otherwise indicated.